Literature DB >> 16830220

The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology.

Henrik von Wenckstern1, Karsten Zimmermann, Burkhard Kleuser.   

Abstract

Sphingosine 1-phosphate (S1P) has been shown to be a bioactive lipid mediator intimately involved in mediating a variety of immunological processes. In particular, S1P regulates lymphocyte cell trafficking between the lymphatic system and the blood. The lysophospholipid signals mainly through five related G protein-coupled receptor subtypes, termed S1P(1) to S1P(5). S1P(1) seems to play an essential role in cell trafficking, as this receptor subtype promotes the egress of T and B cells from secondary lymphatic organs. This S1P(1)-mediated migratory response is a consequence of different S1P levels in the serum and lymphatic organs. In addition to its direct effects on lymphocyte motility, S1P strengthens cell barrier integrity in sinus-lining endothelial cells, thereby reducing lymphocyte egress out of lymph nodes. Furthermore, S1P modulates cytokine profiles in T and dendritic cells, resulting in an elevated differentiation of T helper-2 cells during the T cell activation process. It is of interest that the mode of molecular action of the novel immunomodulator FTY720 interferes with the signaling of S1P. After phosphorylation, FTY720 shares structural similarity with S1P, but in contrast to the natural ligand, phosphorylated FTY720 induces a prolonged internalization of S1P(1), resulting in an impaired S1P-mediated migration of lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16830220     DOI: 10.1007/s00005-006-0028-9

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  9 in total

1.  A novel sphingomyelinase-like enzyme in Ixodes scapularis tick saliva drives host CD4 T cells to express IL-4.

Authors:  F J Alarcon-Chaidez; V D Boppana; A T Hagymasi; A J Adler; S K Wikel
Journal:  Parasite Immunol       Date:  2009-04       Impact factor: 2.280

2.  A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis.

Authors:  Ashley J Snider; Toshihiko Kawamori; Sarah G Bradshaw; K Alexa Orr; Gary S Gilkeson; Yusuf A Hannun; Lina M Obeid
Journal:  FASEB J       Date:  2008-09-24       Impact factor: 5.191

Review 3.  Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate.

Authors:  Cungui Mao; Lina M Obeid
Journal:  Biochim Biophys Acta       Date:  2008-06-13

4.  Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants.

Authors:  Nicole Weis; Andreas Weigert; Andreas von Knethen; Bernhard Brüne
Journal:  Mol Biol Cell       Date:  2009-01-07       Impact factor: 4.138

5.  Compositional changes of B and T cell subtypes during fingolimod treatment in multiple sclerosis patients: a 12-month follow-up study.

Authors:  Nele Claes; Tessa Dhaeze; Judith Fraussen; Bieke Broux; Bart Van Wijmeersch; Piet Stinissen; Raymond Hupperts; Niels Hellings; Veerle Somers
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

6.  Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation.

Authors:  Katja Thomas; Tony Sehr; Undine Proschmann; Francisco Alejandro Rodriguez-Leal; Rocco Haase; Tjalf Ziemssen
Journal:  J Neuroinflammation       Date:  2017-02-23       Impact factor: 8.322

7.  Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Promoted Osteogenesis by Increasing Vesicle Trafficking, Wnt/Ca2+, and BMP/Smad Signaling.

Authors:  Simon Lin; Subramanya Pandruvada; Hong Yu
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

Review 8.  The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance.

Authors:  Run-Ze Li; Xuan-Run Wang; Jian Wang; Chun Xie; Xing-Xia Wang; Hu-Dan Pan; Wei-Yu Meng; Tu-Liang Liang; Jia-Xin Li; Pei-Yu Yan; Qi-Biao Wu; Liang Liu; Xiao-Jun Yao; Elaine Lai-Han Leung
Journal:  Front Oncol       Date:  2022-07-27       Impact factor: 5.738

Review 9.  B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions.

Authors:  Nele Claes; Judith Fraussen; Piet Stinissen; Raymond Hupperts; Veerle Somers
Journal:  Front Immunol       Date:  2015-12-21       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.